DSM, the world’s largest vitamins maker, on Thursday unveiled a restructuring plan to boost profit at its hard-pressed nutrition unit and said it was also weighing sizeable acquisitions and a new share buy-back.

The developments may reassure shareholders concerned that the Dutch company could be a target for activist investors or private equity after a run of disappointing results caused by its failure to offset rising raw material prices.